Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic StrokeBruce Campbell, Gagan Sharma, Peter Mitchell et al.|JAMA|2020Cited by 263
Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trialPeter Mitchell, Justin Whitley, Steven Bush et al.|The Lancet|2022Cited by 225
Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trialMark Parsons, Vignan Yogendrakumar, Leonid Churilov et al.|The Lancet Neurology|2024Cited by 89
Clinical and laboratory factors related to acute isolated vertigo or dizziness and cerebral infarctionLian Zuo, Gang Li, Yiqiang Zhan et al.|Brain and Behavior|2018Cited by 26
Safety and Efficacy of Tenecteplase in Older Patients With Large Vessel OcclusionVignan Yogendrakumar, Benjamin Clissold, Leonid Churilov et al.|Neurology|2022Cited by 23